• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these drugs can affect the fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to consider the benefits of taking it against the potential risks to the baby. Physicians do not have the information needed to provide clear recommendations, but they can provide information about risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a massive population-based case control study to assess the frequency of major structural defects in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was accurate and to reduce any bias.

The study of the researchers had some limitations. Most important, they were not able to differentiate the effects of the medication from those of the underlying disorder. This limitation makes it difficult to know whether the small associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. Additionally the researchers did not examine the long-term outcomes of offspring.

The study found that infants whose mother had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to those whose mothers did not use any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an elevated risk of having a caesarean delivery or having a baby with an low estrogen and adhd medication Apgar score (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications in early pregnancies may be offset by the greater benefits for mother and baby of continuing treatment for the woman's disorder. Doctors should discuss with their patients about this and try to help them improve coping skills which may reduce the effects of her disorder on her daily life and relationships.

Interactions with Medication

Many doctors are confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are taken in the absence of clear and authoritative evidence in either case, which means that doctors must weigh what they know from their own experiences, those of other doctors, and what the research suggests about the subject and their own judgments for each patient.

In particular, the issue of potential risks to the baby can be a challenge. A lot of studies on this issue are based on observational evidence instead of controlled research and their conclusions are often contradictory. The majority of studies focus on live-births, which could underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study discussed in the journal club addresses these limitations by analyzing the data from deceased and live births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects However, other studies haven't established a link. Most studies have shown an unintended, or slightly negative, effect. As a result, a careful risk/benefit analysis is required in every case.

It can be challenging, if not impossible for women with ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. A loss of medication may also affect the ability to safely drive and complete work-related tasks, which are vital aspects of normal life for those suffering from ADHD.

She suggests women who are uncertain about whether to continue or discontinue medication due to their pregnancy, consider informing family members, friends and colleagues about the condition, its impact on daily functioning, and on the advantages of staying on the current treatment regimen. In addition, educating them can help the woman feel supported in her struggle with her decision. It is important to note that some medications are able to pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug can be transferred to the child.

Risk of Birth Defects

As the use of adhd medication weight loss uk medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about the effects that the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two massive datasets to analyze over 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers did find that first-trimester exposure to ADHD medicines was associated with an increased risk of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers behind the study found no connection between early medication use and other congenital anomalies, like facial clefting, or club foot. The results are in the same vein as previous studies that showed an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. The risk increased in the latter stages of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean and also have an insufficient Apgar after delivery and have a baby that needed help breathing when they were born. However the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to the findings.

Researchers hope their research will help doctors when they meet pregnant women. They advise that while discussing the benefits and risks is important however, the decision to stop or continue treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is an option to look into, it is not advised due to the high rate depression and mental health issues genetic testing for adhd medications women who are pregnant or who have recently given birth. Additionally, research suggests that women who stop taking their medications will have a difficult transitioning to life without them after the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD may face a lot of challenges when they have to manage their symptoms, attend doctor appointments, prepare for the birth of a baby and adjust to new routines. As such, many women choose to continue taking their adhd medication not working medications throughout the course of pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk in low amounts. However, the amount of medication exposure to the newborn can vary depending on dosage, how often it is administered and at what time it is administered. In addition, various medications are introduced into the baby's system via the gastrointestinal tract or breast milk. The impact on a newborn's health is not fully known.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult decision for the mother, who must weigh the benefits of continuing her medication against the risks to the fetus. Until more information becomes available, GPs can inquire about pregnant patients if they have an background of ADHD or if they are planning to take medication during the perinatal stage.

A growing number of studies have proven that most women can safely continue taking their ADHD medication during pregnancy and breastfeeding. This has led to an increasing number of patients choose to do so and, in consultation with their physician, they have found that the benefits of continuing their current medication far outweigh any risks.

It is essential for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication dealing with adhd without medication their doctor, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and underlying disorder, learn about available treatments and to reinforce existing strategies for coping. This should be a multidisciplinary approach with the GP, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both mother and child, and monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.